UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

L‐asparaginase treatment in acute lymphoblastic leukemia

Cancer, 2011-01, Vol.117 (2), p.238-249

2011

Volltextzugriff (PDF)

Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia

Haematologica (Roma), 2022-01, Vol.107 (1), p.49-57

2022

Volltextzugriff (PDF)

Bioanalysis of doxorubicin aglycone metabolites in human plasma samples–implications for doxorubicin drug monitoring

Scientific reports, 2020-10, Vol.10 (1), p.18562-18562, Article 18562

2020

Volltextzugriff (PDF)

Comparison of self-reported physical activity in children and adolescents before and during cancer treatment

Pediatric blood & cancer, 2014-06, Vol.61 (6), p.1023-1028

2014

Volltextzugriff (PDF)

Therapeutic Drug Monitoring of Asparaginase: Intra-individual Variability and Predictivity in Children With Acute Lymphoblastic Leukemia Treated With PEG-Asparaginase in the AIEOP-BFM Acute Lymphoblastic Leukemia 2009 Study

Therapeutic drug monitoring, 2020-06, Vol.42 (3), p.435-444

2020

Volltextzugriff (PDF)

Objectively measured versus self-reported physical activity in children and adolescents with cancer

PloS one, 2017-02, Vol.12 (2), p.e0172216-e0172216

2017

Volltextzugriff (PDF)

Adverse Events During Supervised Exercise Interventions in Pediatric Oncology—A Nationwide Survey

Frontiers in pediatrics, 2021-08, Vol.9, p.682496-682496

2021

Volltextzugriff (PDF)

The toxicity of very prolonged courses of PEGasparaginase or Erwinia asparaginase in relation to asparaginase activity, with a special focus on dyslipidemia

Haematologica (Roma), 2014-11, Vol.99 (11), p.1716-1721

2014

Volltextzugriff (PDF)

Physical activity and childhood cancer

Pediatric blood & cancer, 2010-04, Vol.54 (4), p.501-510

2010

Volltextzugriff (PDF)

Level of activity in children undergoing cancer treatment

Pediatric blood & cancer, 2009-09, Vol.53 (3), p.438-443

2009

Volltextzugriff (PDF)

Improved 6‐year overall survival in AT/RT – results of the registry study Rhabdoid 2007

Cancer medicine (Malden, MA), 2016-08, Vol.5 (8), p.1765-1775

2016

Volltextzugriff (PDF)

Feasibility and effects of a home-based intervention using activity trackers on achievement of individual goals, quality of life and motor performance in patients with paediatric cancer

BMJ Open Sport & Exercise Medicine, 2018, Vol.4 (1), p.e000322-e000322

2018

Volltextzugriff (PDF)

Population Pharmacokinetics of Escalating Doses of Caspofungin in a Phase II Study of Patients with Invasive Aspergillosis

Antimicrobial Agents and Chemotherapy, 2013-04, Vol.57 (4), p.1664-1671

2013

Volltextzugriff (PDF)

Population Pharmacokinetics of Liposomal Amphotericin B and Caspofungin in Allogeneic Hematopoietic Stem Cell Recipients

Antimicrobial Agents and Chemotherapy, 2012-01, Vol.56 (1), p.536-543

2012

Volltextzugriff (PDF)

Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years

Cancer chemotherapy and pharmacology, 2013-03, Vol.71 (3), p.749-763

2013

Volltextzugriff (PDF)

Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure

BMC pharmacology & toxicology, 2020-05, Vol.21 (1), p.37-10, Article 37

2020

Volltextzugriff (PDF)

Potentiale von Windsurfen für Menschen mit sonderpädagogischem Förderbedarf

Sportunterricht, 2018, Vol.67 (8), p.352-355

2018

Volltextzugriff (PDF)

Cytotoxicity of Dimethylacetamide and Pharmacokinetics in Children Receiving Intravenous Busulfan

Journal of clinical oncology, 2007-05, Vol.25 (13), p.1772-1778

2007

Volltextzugriff (PDF)

Early decrements in bone density after completion of neoadjuvant chemotherapy in pediatric bone sarcoma patients

BMC musculoskeletal disorders, 2010-12, Vol.11 (1), p.287-287, Article 287

2010

Volltextzugriff (PDF)

Monitoring of N, N-dimethylacetamide in children during i.v.-busulfan therapy by liquid chromatography–mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2006-07, Vol.838 (2), p.129-134

2006

Volltextzugriff (PDF)

Preclinical Evaluation of Combined Topoisomerase and Proteasome Inhibition Against Pediatric Malignancies

Anticancer research, 2018-07, Vol.38 (7), p.3977-3984

2018

Volltextzugriff (PDF)

1 – 25 von 214

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(178)

Publikationsform

Sprache

Englisch
(190)
Deutsch
(26)

Erscheinungsjahr

n.n

Thema

Science & Technology
(140)
Life Sciences & Biomedicine
(135)
Humans
(125)
Child
(80)
Oncology
(73)
Adolescent
(62)
Female
(57)
Male
(56)
Child, Preschool
(55)
Biological And Medical Sciences
(49)
Medical Sciences
(48)
Pharmacology & Pharmacy
(46)
Pharmacology. Drug Treatments
(43)
Infant
(42)
Hematology
(41)
Pediatrics
(40)
Antineoplastic Agents
(25)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapy
(25)
Adult
(24)
Dose-Response Relationship, Drug
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

L‐asparaginase treatment in acute lymphoblastic leukemia

Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia

Bioanalysis of doxorubicin aglycone metabolites in human plasma samples–implications for doxorubicin drug monitoring

Comparison of self-reported physical activity in children and adolescents before and during cancer treatment

Therapeutic Drug Monitoring of Asparaginase: Intra-individual Variability and Predictivity in Children With Acute Lymphoblastic Leukemia Treated With PEG-Asparaginase in the AIEOP-BFM Acute Lymphoblastic Leukemia 2009 Study

Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

Objectively measured versus self-reported physical activity in children and adolescents with cancer

Adverse Events During Supervised Exercise Interventions in Pediatric Oncology—A Nationwide Survey

The toxicity of very prolonged courses of PEGasparaginase or Erwinia asparaginase in relation to asparaginase activity, with a special focus on dyslipidemia

Physical activity and childhood cancer

Level of activity in children undergoing cancer treatment

Improved 6‐year overall survival in AT/RT – results of the registry study Rhabdoid 2007

Feasibility and effects of a home-based intervention using activity trackers on achievement of individual goals, quality of life and motor performance in patients with paediatric cancer

Population Pharmacokinetics of Escalating Doses of Caspofungin in a Phase II Study of Patients with Invasive Aspergillosis

Incidence and Characteristics of Hypersensitivity Reactions to PEG‐asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP‐BFM ALL 2009 Study Protocol

Population Pharmacokinetics of Liposomal Amphotericin B and Caspofungin in Allogeneic Hematopoietic Stem Cell Recipients

Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years

Hypersensitivity Reactions to Native E. coli L‐asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL‐BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction

Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure

Potentiale von Windsurfen für Menschen mit sonderpädagogischem Förderbedarf

Cytotoxicity of Dimethylacetamide and Pharmacokinetics in Children Receiving Intravenous Busulfan

Early decrements in bone density after completion of neoadjuvant chemotherapy in pediatric bone sarcoma patients

Monitoring of N, N-dimethylacetamide in children during i.v.-busulfan therapy by liquid chromatography–mass spectrometry

Preclinical Evaluation of Combined Topoisomerase and Proteasome Inhibition Against Pediatric Malignancies

Suchergebnisse filtern